Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 217.50
+1.50 (0.69%)
Jun 19, 2026, 9:06 AM GMT
Spire Healthcare Group Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.4 | 25.4 | 27.3 | 8.6 | -9.7 |
Depreciation & Amortization | 117 | 109.9 | 103.2 | 97.9 | 97.1 |
Other Amortization | 4.1 | 3.8 | 1.9 | 4.6 | - |
Loss (Gain) From Sale of Assets | 0.5 | -5.2 | -0.3 | 0.8 | -23.5 |
Loss (Gain) From Sale of Investments | -3.1 | -5.8 | -3.6 | -3 | - |
Stock-Based Compensation | 2.1 | 4.2 | 3.7 | 2.3 | 2.8 |
Other Operating Activities | 110.4 | 110.4 | 98.8 | 85.4 | 105.7 |
Change in Accounts Receivable | -5.1 | -11 | -12.7 | -6.9 | 1.7 |
Change in Inventory | 0.4 | -2.3 | -3.7 | -0.4 | -1.9 |
Change in Accounts Payable | -2.6 | 9 | 2.2 | 8.2 | 14.3 |
Change in Other Net Operating Assets | 2.1 | -2.7 | -1.3 | -15.9 | -2.7 |
Operating Cash Flow | 242.2 | 235.7 | 215.5 | 181.6 | 183.8 |
Operating Cash Flow Growth | 2.76% | 9.37% | 18.67% | -1.20% | 15.09% |
Capital Expenditures | -76.3 | -109.3 | -83.9 | -87.7 | -69.3 |
Sale of Property, Plant & Equipment | - | 11.7 | 0.8 | 3.2 | 35.3 |
Cash Acquisitions | -7.7 | - | -73.2 | -11.3 | -14.7 |
Sale (Purchase) of Intangibles | -2.2 | -2.8 | -0.5 | - | - |
Investment in Securities | 1 | 0.7 | 0.7 | 0.5 | 0.4 |
Other Investing Activities | 1 | 0.7 | -1.1 | - | - |
Investing Cash Flow | -84.2 | -99 | -157.2 | -95.3 | -48.3 |
Short-Term Debt Issued | 55 | 5 | - | - | - |
Long-Term Debt Issued | - | - | 60 | 325 | - |
Total Debt Issued | 55 | 5 | 60 | 325 | - |
Short-Term Debt Repaid | -55 | -5 | - | - | - |
Long-Term Debt Repaid | -35.1 | -26.2 | -47.2 | -445.2 | -14.7 |
Total Debt Repaid | -90.1 | -31.2 | -47.2 | -445.2 | -14.7 |
Net Debt Issued (Repaid) | -35.1 | -26.2 | 12.8 | -120.2 | -14.7 |
Issuance of Common Stock | 2.2 | - | - | 3.1 | - |
Repurchase of Common Stock | -11.7 | -11.6 | -3.1 | - | - |
Common Dividends Paid | -9.2 | -8.5 | -2 | -0.1 | - |
Other Financing Activities | -110.7 | -98.8 | -90.6 | -97.5 | -24.5 |
Financing Cash Flow | -164.5 | -145.1 | -82.9 | -214.7 | -39.2 |
Net Cash Flow | -6.5 | -8.4 | -24.6 | -128.4 | 96.3 |
Free Cash Flow | 165.9 | 126.4 | 131.6 | 93.9 | 114.5 |
Free Cash Flow Growth | 31.25% | -3.95% | 40.15% | -17.99% | 1.24% |
Free Cash Flow Margin | 10.50% | 8.36% | 9.68% | 7.83% | 10.35% |
Free Cash Flow Per Share | 0.41 | 0.31 | 0.32 | 0.23 | 0.29 |
Cash Interest Paid | 105 | 98.1 | 90 | 94.6 | 80 |
Cash Income Tax Paid | 0.2 | 0.1 | 0.1 | 0.1 | - |
Levered Free Cash Flow | 66.41 | 39.01 | 50.16 | 8.64 | 65.13 |
Unlevered Free Cash Flow | 129.6 | 99.01 | 105.85 | 57.73 | 119.5 |
Change in Working Capital | -5.2 | -7 | -15.5 | -15 | 11.4 |